| Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients SK Barta, X Xue, D Wang, R Tamari, JY Lee, N Mounier, LD Kaplan, ... Blood, The Journal of the American Society of Hematology 122 (19), 3251-3262, 2013 | 219 | 2013 |
| Human immunodeficiency virus‐associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy JJ Castillo, M Furman, BE Beltrán, M Bibas, M Bower, W Chen, ... Cancer 118 (21), 5270-5277, 2012 | 187 | 2012 |
| Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related … B Xicoy, JM Ribera, P Miralles, J Berenguer, R Rubio, B Mahillo, ... Haematologica 92 (2), 191-198, 2007 | 138 | 2007 |
| Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma … JT Navarro, JM Ribera, A Oriol, M Vaquero, J Romeu, M Batlle, A Flores, ... British journal of haematology 112 (4), 909-915, 2001 | 117 | 2001 |
| Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine JT Navarro, JM Ribera, JL Mate, I Granada, J Juncà, M Batlle, F Millá, ... Leukemia & lymphoma 44 (3), 531-533, 2003 | 94 | 2003 |
| Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas G Tapia, R Lopez, AM Muñoz‐Mármol, JL Mate, C Sanz, R Marginet, ... Histopathology 59 (4), 672-678, 2011 | 92 | 2011 |
| Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL JT Navarro, JA Hernández, JM Ribera, JM Sancho, A Oriol, M Pujol, ... Haematologica 83 (11), 998-1000, 1998 | 85 | 1998 |
| Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma JJ Castillo, T Guerrero-Garcia, F Baldini, E Tchernonog, G Cartron, ... British journal of haematology 184 (4), 679-682, 2019 | 76 | 2019 |
| International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 … JT Navarro, JM Ribera, A Oriol, M Vaquero, J Romeu, M Batlle, J Gómez, ... Haematologica 83 (6), 508-513, 1998 | 76 | 1998 |
| HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era MJ Baptista, O Garcia, M Morgades, E Gonzalez-Barca, P Miralles, ... Aids 29 (7), 811-818, 2015 | 57 | 2015 |
| Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease JM Ribera, JT Navarro, A Oriol, A López-Guillermo, A Sureda, E Abella, ... Aids 16 (14), 1973-1976, 2002 | 52 | 2002 |
| The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative … JT Navarro, N Lloveras, JM Ribera, A Oriol, JL Mate, E Feliu Haematologica 90 (5), 704-706, 2005 | 50 | 2005 |
| Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry B Espinet, A Ferrer, B Bellosillo, L Nonell, A Salar, ... Clinical Cancer Research 20 (4), 1007-1019, 2014 | 47 | 2014 |
| Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome R Esteve-Puig, F Climent, D Piñeyro, E Domingo-Domènech, V Davalos, ... Blood, The Journal of the American Society of Hematology 137 (7), 994-999, 2021 | 41 | 2021 |
| Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia‐positive chronic myeloid leukemia: two cases with a different outcome JT Navarro, E Feliu, J Grau, B Espinet, D Colomer, JM Ribera, A Oriol, ... American journal of hematology 82 (9), 849-851, 2007 | 40 | 2007 |
| MYC protein expression is associated with poor prognosis in primary diffuse large B‐cell lymphoma of the central nervous system G Tapia, MJ Baptista, AM Muñoz‐Marmol, A Gaafar, M Puente‐Pomposo, ... Apmis 123 (7), 596-603, 2015 | 38 | 2015 |
| Translocation (3; 8)(q27; q24) in two cases of triple hit lymphoma C Motlló, J Grau, J Juncà, N Ruiz, JL Mate, E Orna, JT Navarro, S Vives, ... Cancer Genetics and Cytogenetics 203 (2), 328-332, 2010 | 38 | 2010 |
| Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma JL Mate, JT Navarro, A Ariza, JM Ribera, E Castellà, J Juncà, C Tural, ... Human pathology 35 (5), 632-635, 2004 | 38 | 2004 |
| Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART JT Navarro, F Vall-Llovera, JL Mate, M Morgades, E Feliu, JM Ribera Haematologica 93 (1), 149-150, 2008 | 36 | 2008 |
| Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F … JM Raya, L Arenillas, A Domingo, B Bellosillo, G Gutiérrez, E Luno, ... International journal of hematology 88, 387-395, 2008 | 35 | 2008 |
